Drug Shortage Report for MYL-ESOMEPRAZOLE
Report ID | 248183 |
Drug Identification Number | 02479427 |
Brand name | MYL-ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-02-10 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2025-02-12 | French | Compare |
v7 | 2025-02-12 | English | Compare |
v6 | 2025-02-05 | French | Compare |
v5 | 2025-02-05 | English | Compare |
v4 | 2025-01-28 | French | Compare |
v3 | 2025-01-28 | English | Compare |
v2 | 2025-01-21 | French | Compare |
v1 | 2025-01-21 | English | Compare |
Showing 1 to 8 of 8